Adjunctive Thymosin Beta-4 Treatment Influences PMN Effector Cell Function during Pseudomonas aeruginosa-Induced Corneal Infection

Previous work examining the therapeutic efficacy of adjunct thymosin beta 4 (Tβ4) to ciprofloxacin for ocular infectious disease has revealed markedly reduced inflammation (inflammatory mediators and innate immune cells) with increased activation of wound healing pathways. Understanding the therapeu...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yuxin, Carion, Thomas W., Ebrahim, Abdul Shukkur, Sosne, Gabriel, Berger, Elizabeth A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8700181/
https://www.ncbi.nlm.nih.gov/pubmed/34944086
http://dx.doi.org/10.3390/cells10123579

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8700181/
https://www.ncbi.nlm.nih.gov/pubmed/34944086
http://dx.doi.org/10.3390/cells10123579

Ejemplares similares